PTAB Newsletter

In this issue:

• Q&A with Arnold & Porter PTAB Practitioner Paul Margulies

• Q&A with Arnold & Porter PTAB Practitioner Lindsey Staubach

• IPR Involving Fintiv Analysis: Volvo Penta of the Americas, LLC v. Brunswick Corp., IPR2022-01366, IPR2022-01367, IPR2022-01368, IPR2022-01369 & IPR2022-01424, Paper No. 15 (PTAB May 2, 2023)

• Federal Circuit Precedential Decision: Board’s Allegedly Incorrect Claim Construction Was Harmless Error Because Patent Owner Failed To Demonstrate That the Board Actually Relied — Or Even Might Have Relied — On the Incorrect Construction in Its Unpatentability Determination. Bot M8 LLC v. Sony Interactive Entertainment LLC, No. 2022-1291 (Fed. Cir. May 9, 2023).

• Federal Circuit Precedential Decision: Federal Circuit Clarifies the Analogous Art Test Asks Whether the Prior Art Reference Is Analogous to the Challenged Patent, Not Whether It Is Analogous to the Other Prior Art to Which It Is Being Combined. Sanofi-Aventis Deutschland GmbH v. Mylan Pharms. Inc., No. 2021- 1981 (Fed. Cir. May 9, 2023)

• Patent Trial and Appeal Board Granted Motion for Sanctions: Spectrum Solutions LLC v. Longhorn Vaccines & Diagnostics, LLC, IPR2021-00847, Paper 107 (May 3, 2023).

• Grant of Director Review Regarding Inclusion of Real Parties in Interest: Unified Patents, LLC v. MemoryWeb, LLC, IPR2021-01413, Paper 76 (May 22, 2023).

• USPTO Proposals

• Events and Speaking Engagements

© Arnold & Porter Kaye Scholer LLP 2023 All Rights Reserved. This newsletter is intended to be a general summary of the law and does not constitute legal advice. You should consult with counsel to determine applicable legal requirements in a specific fact situation.